产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 现货 | |||
| 5mg | 98% | 现货 | |||
| 10mg | 98% | 现货 | |||
| 25mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 | |||
| 5g | 98% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 现货 | |||
| 5mg | 98% | 现货 | |||
| 10mg | 98% | 现货 | |||
| 25mg | 98% | 现货 | |||
| 100mg | 98% | 现货 | |||
| 250mg | 98% | 现货 | |||
| 1g | 98% | 现货 | |||
| 5g | 98% | 现货 |
CAS No. |
64924-67-0 |
|---|---|
中文名称 |
7-溴-6-氯-3-(3-((2S,3R)-rel-3-羟基-2-哌啶基)-丙基-2-酮基]-4(3H)-喹唑啉酮氢溴酸盐 |
英文名称 |
7-Bromo-6-chloro-3-(3-((2S,3R)-rel-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one hydrobromide |
别名 |
MFCD00017259 | RU-19110 (hydrobromide) | Halofuginone hydrobromide, (-)- | AMY26820 | HY-N1584A | AKOS015920268 | CS-0081860 | Halofuginonehydrobromide | Halofuginone (hydrobromide) | 4(3H)-Quinazolinone, 7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2- |
标准英文名 |
7-Bromo-6-chloro-3-(3-((2S,3R)-rel-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one hydrobromide |
MDL No. |
MFCD00946455 |
分子式 |
C16H18Br2ClN3O3 |
分子量 |
495.60 |
精确分子量 |
492.94 |
SMILES |
O=C1N(CC(C[C@H]2NCCC[C@@H]2O)=O)C=NC3=C1C=C(Cl)C(Br)=C3.[H]Br |
标准SMILES |
Br.O[C@H]1CCCN[C@@H]1CC(=O)CN1C=NC2C=C(Br)C(Cl)=CC=2C1=O |
性状 |
White to Yellow Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
SJUWEPZBTXEUMU-LIOBNPLQSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
Keep in dark place,Inert atmosphere,Room temperature,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory tract irritation (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|